Ustekinumab Has Longer Efficacy Duration than TNFIs for Plaque Psoriasis Michele B. Kaufman, PharmD, BCGP | March 28, 2017When compared with TNFIs, ustekinumab demonstrated a longer drug survival rate in patients with severe plaque psoriasis…
